Bioequivalence, Safety, and Tolerability of Ponesimod Capsules vs. Tablets in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 30 Jun 2015
At a glance
- Drugs Ponesimod (Primary)
- Indications Graft-versus-host disease; Immunological disorders; Multiple sclerosis; Plaque psoriasis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Actelion Pharmaceuticals
- 25 Mar 2013 New trial record
- 09 Mar 2013 Results presented at the 114th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.